MYELOID LEUKEMIA
Clinical trials for MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat leukemia: old drug shows promise in combo therapy
Disease control Recruiting nowThis early-stage study tests whether adding mitoxantrone to the usual venetoclax+azacitidine regimen can help adults with acute myeloid leukemia (AML) whose cancer did not respond or came back after initial treatment. About 30 participants will receive different doses to find the…
Matched conditions: MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Exercise plus supplement may rebuild muscle in young transplant survivors
Disease control Recruiting nowThis study tests whether a tailored exercise program combined with a dietary supplement called nicotinamide riboside (NR) can improve muscle mass, strength, and fitness in adolescents and young adults who had a bone marrow transplant for leukemia or other blood disorders. About 8…
Matched conditions: MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New pill shows promise for leukemia patients who've run out of options
Disease control Recruiting nowThis study tests an oral drug called HQP1351 in people with chronic myeloid leukemia (CML) or a type of acute lymphoblastic leukemia (Ph+ ALL) that has not responded to at least two other treatments. The goal is to find the right dose and see how safe and effective the drug is. A…
Matched conditions: MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Exercise may turn back the clock for blood cancer survivors
Knowledge-focused Recruiting nowThis study looks at whether a tailored exercise program can help older blood cancer survivors slow down the aging process. Researchers will enroll 180 people aged 50 and older who have had blood cancer. The goal is to see if participants can stick with the exercise plan and if it…
Matched conditions: MYELOID LEUKEMIA
Phase: NA • Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC